A novel actinobacterium species from a mangrove ecosystem- antibacterial activity and chemical characterization

Abstract

The discovery of streptomycin by Selman Waksman (1943) brought into focus a new avenue of drugs from natural products, i.e., actinobacterial secondary metabolites. It forms more than 60 % of total bacterial secondary metabolites (mostly from Streptomyces). Interestingly, rare Actinobacteria can produce novel secondary metabolites with unique chemical structures. With the rise of drug resistant microbes, focus on actinobacterial research has shifted towards exploring unusual niches such as those located along land-ocean boundary where freshwater mixes with saltwater. One such ecosystem is the Sundarbans mangrove, located at the apex of Bay of Bengal. The present study aims to identify novel actinobacterial species from Sundarbans which has the ability to produce unique secondary metabolites. Mangrove sediments were collected, overall bacterial diversity and secondary metabolites producing bacterial diversity were elucidated by 16S rRNA and polyketide synthase (PKS) clone library approaches respectively. Fifteen bacterial strains were isolated from the sediment using cultured approach, among which, an isolate I2 was identified based on polyphasic taxonomy. The I2 represents a new species, Myceligenerans indicum sp. nov. This new species also possess PKS genes which indicate ability to produce secondary metabolite(s). Promising antibacterial activity of this new species was found against Escherchia coli XL10, Bacillus subtilis and Vibrio chemaguriensis Iso1 especially for fraction prepared using acetone and dichloromethane (1 : 1). Spectroscopic approaches have revealed the presence of functional groups such as amide, allene, isothiocyanate and ketenimine groups.